Market
Region Most Impacted by Eli Lilly Wisconsin $3B Investment by End of 2026?
2
Resolution / Starting Odds
Pleasant Prairie • 25%
Greater Wisconsin Area • 25%
Midwest Region • 25%
Other • 25%
Economic reports or analyses from regional economic boards
Story
Eli Lilly Boosts Wisconsin Plant with $3B Investment, Adding 750 Jobs
Dec 5, 2024, 08:33 PM
Eli Lilly and Co. has announced a significant investment of $3 billion to expand its manufacturing facility in Pleasant Prairie, Wisconsin. The expansion aims to increase production capacity for diabetes and obesity medicines, responding to the soaring demand for these treatments. This move is part of a broader $23 billion investment in global manufacturing since 2020. The expansion is expected to create 750 new jobs and will benefit millions of patients globally by enhancing the supply of Lilly's weight-loss and diabetes drugs.
View original story
Similar markets
Europe • 25%
Other • 25%
North America • 25%
Asia • 25%
Northeast • 25%
West • 25%
South • 25%
Midwest • 25%
Digital Health • 25%
Genomics • 25%
AI in Drug Discovery • 25%
Other • 25%
Other • 25%
Oklahoma • 25%
Texas • 25%
California • 25%
California • 25%
Other • 25%
New York • 25%
Texas • 25%
More than $300M • 25%
Less than $100M • 25%
$100M to $200M • 25%
$200M to $300M • 25%
Texas • 25%
California • 25%
New York • 25%
Florida • 25%